Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2023-06-12 | ALGER ASSOCIATES INC | CORE LABORATORIES N V | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-14 | ARIEL INVESTMENTS, LLC | CORE LABORATORIES N V | - | - | EDGAR |
SC 13G/A | 2023-02-14 | EARNEST PARTNERS LLC | CORE LABORATORIES N V | 3,573,101 | 7.7% | EDGAR |
SC 13G/A | 2023-02-14 | ALGER ASSOCIATES INC | CORE LABORATORIES N V | 3,853,977 | 8.3% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | CORE LABORATORIES N V | 5,262,192 | 11.4% | EDGAR |
SC 13G/A | 2023-01-26 | BlackRock Inc. | CORE LABORATORIES N V | 5,848,677 | 12.6% | EDGAR |
SC 13G/A | 2023-01-20 | BlackRock Inc. | CORE LABORATORIES N V | 5,848,677 | 12.6% | EDGAR |
SC 13G/A | 2022-02-14 | ARIEL INVESTMENTS, LLC | CORE LABORATORIES N V | - | - | EDGAR |
SC 13G/A | 2022-02-11 | EARNEST PARTNERS LLC | CORE LABORATORIES N V | 3,433,430 | 7.4% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | CORE LABORATORIES N V | 4,967,126 | 10.7% | EDGAR |
SC 13G/A | 2022-01-27 | BlackRock Inc. | CORE LABORATORIES N V | 5,362,893 | 11.6% | EDGAR |
SC 13G/A | 2022-01-26 | BlackRock Inc. | CORE LABORATORIES N V | 5,362,893 | 11.6% | EDGAR |
SC 13G/A | 2022-01-10 | ALGER ASSOCIATES INC | CORE LABORATORIES N V | 4,019,235 | 8.7% | EDGAR |
SC 13G/A | 2022-01-04 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | CORE LABORATORIES N V | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-12-10 | ARIEL INVESTMENTS, LLC | CORE LABORATORIES N V | - | - | EDGAR |
SC 13G/A | 2021-06-10 | ALGER ASSOCIATES INC | CORE LABORATORIES N V | 6,511,232 | 14.1% | EDGAR |
SC 13G/A | 2021-02-16 | EARNEST PARTNERS LLC | CORE LABORATORIES N V | 4,266,748 | 9.6% | EDGAR |
SC 13G | 2021-02-16 | ALGER ASSOCIATES INC | CORE LABORATORIES N V | 2,364,146 | 5.3% | EDGAR |
SC 13G/A | 2021-02-12 | ARIEL INVESTMENTS, LLC | CORE LABORATORIES N V | - | - | EDGAR |
SC 13G/A | 2021-02-11 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | CORE LABORATORIES N V | 2,985,320 | 6.7% | EDGAR |